Volume | 128,704 |
|
|||||
News | - | ||||||
Day High | 0.613 | Low High |
|||||
Day Low | 0.59 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
VBI Vaccines Inc | VBIV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.61 | 0.59 | 0.613 | 0.6026 | 0.58 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
502 | 128,704 | $ 0.6055692 | $ 77,939 | - | 0.45 - 10.47 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:56:24 | formt | 1,200 | $ 0.5698 | USD |
VBI Vaccines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
14.45M | 23.69M | - | 1.08M | -113.3M | -4.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
VBI Vaccines News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VBIV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.597 | 0.613 | 0.555 | 0.574144 | 60,254 | -0.0272 | -4.56% |
1 Month | 0.56 | 0.636 | 0.555 | 0.5835398 | 74,085 | 0.0098 | 1.75% |
3 Months | 0.62 | 0.7588 | 0.53 | 0.6137663 | 121,918 | -0.0502 | -8.10% |
6 Months | 0.6893 | 0.7599 | 0.45 | 0.6103745 | 126,653 | -0.1195 | -17.34% |
1 Year | 8.934 | 10.47 | 0.45 | 2.73 | 633,770 | -8.36 | -93.62% |
3 Years | 92.10 | 129.30 | 0.45 | 57.14 | 1,637,270 | -91.53 | -99.38% |
5 Years | 56.10 | 217.20 | 0.45 | 74.56 | 3,529,391 | -55.53 | -98.98% |
VBI Vaccines Description
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. |